论文部分内容阅读
头孢洛林(ceftaroline,PPI-0903M,T-91825)由头孢唑兰(cefozopran)衍生得到。作用机制与β-内酰胺类抗生素一致,与青霉素结合蛋白(PBPs)结合起作用。该药对金葡菌[包括耐甲氧西林金葡菌(MRSA)、万古霉素中度耐药金葡菌(VISA)、异质性耐药VISA(hVISA)和万古霉素耐药金葡菌(VRSA)]、肺炎链球菌(包括耐药菌株)等革兰阳性菌和呼吸道革兰阴性菌
Ceftaroline (PPI-0903M, T-91825) is derived from cefozopran. The mechanism of action is consistent with β-lactam antibiotics and with penicillin-binding proteins (PBPs). The drug against Staphylococcus aureus [including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Staphylococcus aureus (VISA), heterogeneous drug-resistant VISA (hVISA) and vancomycin-resistant gold (VRSA)], Streptococcus pneumoniae (including resistant strains) and Gram-positive bacteria and respiratory Gram-negative bacteria